Kestra Advisory Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kestra Advisory Services’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,154	Closed	-$2.42M	–	2052
2021 Q1	$2.42M	Sell	11,154 -4,719	-30%	-$887K	0.03%	534
2020 Q4	$1.84M	Buy	15,873 +816	+5%	+$91.4K	0.02%	621
2020 Q3	$1.47M	Buy	+15,057	New	+$1.73M	0.03%	506

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Kestra Advisory Services's GWPH Position: Q2 2021 in Review

Kestra Advisory Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 11,154 shares — an estimated $2.42M sold.

Kestra Advisory Services first reported a position in GWPH in Q3 2020 and held it in 3 quarters. The position peaked at $2.42M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Kestra Advisory Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Kestra Advisory Services sold 11,154 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2.42M.
Kestra Advisory Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 3 quarters.
Kestra Advisory Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.42M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Kestra Advisory Services's 13F filing for Q2 2021, filed 28 Jul 2021.